Article
Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation.
Brain & development - 1 May 2016
Di Meglio Chloé, Bonello-Palot Nathalie, Boulay Christophe, Milh Mathieu, Ovaert Caroline, Levy Nicolas, Chabrol Brigitte
Abstract excerpt
INTRODUCTION: The Mitofusin 2 gene (MFN2), which encodes a mitochondrial membrane protein, is known to be the first cause of autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2) with early onset. This gene is involved in typical CMT2A and in more atypical phenotypes as optic atrophy or spastic paraplegia. CMT2 refers to inherited axonal polyneuropathy, which associates progressive peripheral motor and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
